[ { "@id": "http://purl.org/np/RAernolO7GGtunEFSL8kiQo3lOLpZMMn-Kxj2_gLFAwe4#provenance", "@graph": [ { "@id": "http://purl.org/np/RAernolO7GGtunEFSL8kiQo3lOLpZMMn-Kxj2_gLFAwe4#assertion", "http://www.w3.org/ns/prov#wasAttributedTo": [ { "@id": "https://orcid.org/0000-0002-1468-3557" } ] } ] }, { "@id": "http://purl.org/np/RAernolO7GGtunEFSL8kiQo3lOLpZMMn-Kxj2_gLFAwe4#Head", "@graph": [ { "@id": "http://purl.org/np/RAernolO7GGtunEFSL8kiQo3lOLpZMMn-Kxj2_gLFAwe4", "http://www.nanopub.org/nschema#hasAssertion": [ { "@id": "http://purl.org/np/RAernolO7GGtunEFSL8kiQo3lOLpZMMn-Kxj2_gLFAwe4#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance": [ { "@id": "http://purl.org/np/RAernolO7GGtunEFSL8kiQo3lOLpZMMn-Kxj2_gLFAwe4#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo": [ { "@id": "http://purl.org/np/RAernolO7GGtunEFSL8kiQo3lOLpZMMn-Kxj2_gLFAwe4#pubinfo" } ], "@type": [ "http://www.nanopub.org/nschema#Nanopublication" ] } ] }, { "@id": "http://purl.org/np/RAernolO7GGtunEFSL8kiQo3lOLpZMMn-Kxj2_gLFAwe4#assertion", "@graph": [ { "@id": "http://purl.obolibrary.org/obo/DOID_3590", "https://w3id.org/biolink/vocab/category": [ { "@id": "https://w3id.org/biolink/vocab/Disease" } ] }, { "@id": "http://purl.org/np/RAernolO7GGtunEFSL8kiQo3lOLpZMMn-Kxj2_gLFAwe4#association", "http://www.w3.org/1999/02/22-rdf-syntax-ns#object": [ { "@id": "http://purl.obolibrary.org/obo/DOID_3590" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate": [ { "@id": "https://w3id.org/biolink/vocab/treats" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject": [ { "@id": "https://identifiers.org/drugbank:DB00970" } ], "@type": [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ], "http://www.w3.org/2000/01/rdf-schema#label": [ { "@value": "dactinomycin for injection is an actinomycin indicated for the treatment of 1 1 1 2 1 3 1 4 1 5 1 6 dactinomycin for injection is indicated for the treatment of adult and pediatric patients with wilms tumor as part of a multi phase combination chemotherapy regimen dactinomycin for injection is indicated for the treatment of adult and pediatric patients with rhabdomyosarcoma as part of a multi phase combination chemotherapy regimen dactinomycin for injection is indicated for the treatment of adult and pediatric patients with ewing sarcoma as part of a multi phase combination chemotherapy regimen dactinomycin for injection is indicated for the treatment of adult and pediatric patients with metastatic nonseminomatous testicular cancer as part of a multi phase combination chemotherapy regimen dactinomycin for injection is indicated for the treatment of post menarchal patients with gestational trophoblastic neoplasia as a single agent or as part of a combination chemotherapy regimen dactinomycin for injection is indicated for the treatment of adult patients with locally recurrent or locoregional solid malignancies as a component of palliative or adjunctive regional perfusion" } ], "https://w3id.org/biolink/vocab/association_type": [ { "@id": "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation" } ], "https://w3id.org/biolink/vocab/provided_by": [ { "@id": "https://w3id.org/um/NeuroDKG" } ], "https://w3id.org/biolink/vocab/relation": [ { "@id": "https://schema.org/TreatmentIndication" } ] }, { "@id": "https://identifiers.org/drugbank:DB00970", "https://w3id.org/biolink/vocab/category": [ { "@id": "https://w3id.org/biolink/vocab/Drug" } ] } ] }, { "@id": "http://purl.org/np/RAernolO7GGtunEFSL8kiQo3lOLpZMMn-Kxj2_gLFAwe4#pubinfo", "@graph": [ { "@id": "http://purl.org/np/RAernolO7GGtunEFSL8kiQo3lOLpZMMn-Kxj2_gLFAwe4#sig", "http://purl.org/nanopub/x/hasAlgorithm": [ { "@value": "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey": [ { "@value": "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature": [ { "@value": "jIYN3kXQ1wWwAqhsofAUItXMdR2MYW+elkX8ELXcLN+fejPd3yhlNaWAGDt09RucJbZHQjOx3qle2kQZBzvYeMwOUCDnOpQsyjGmBD8ptPkz5lkw5bjg8mU9vo3SnB7Z4sKyZgx+ZPftKM9tAVqoNxUQ5azETu9fIaOIOdb1ToM=" } ], "http://purl.org/nanopub/x/hasSignatureTarget": [ { "@id": "http://purl.org/np/RAernolO7GGtunEFSL8kiQo3lOLpZMMn-Kxj2_gLFAwe4" } ] }, { "@id": "http://purl.org/np/RAernolO7GGtunEFSL8kiQo3lOLpZMMn-Kxj2_gLFAwe4", "http://purl.org/dc/terms/created": [ { "@value": "2021-06-13T14:19:57.785+02:00", "@type": "http://www.w3.org/2001/XMLSchema#dateTime" } ], "http://purl.org/dc/terms/creator": [ { "@id": "https://orcid.org/0000-0002-1468-3557" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate": [ { "@id": "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate": [ { "@id": "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM" } ], "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate": [ { "@id": "http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs" } ] } ] } ]